Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-12

Clinical Trial Update: Metabolomic Profiling of Novel Mediators of Vascular Function

View source ↗

Summary

A terminated clinical trial evaluating metabolomic mediators of vascular function in individuals with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes Mellitus | Status: TERMINATED